glp-1 in brain Hunting for heroes: neurons mediating GLP-1R agonists obesity treatment GLP-1 receptors are present in

The GLP-1 receptor agonists included dulaglutide (Trulicity, Eli Lilly), liraglutide (Saxenda, Novo Nordisk), exenatide (Bydureon, AstraZeneca), tirzepatide (Zepbound, Eli Lilly) and semaglutide

[15] [16] Clinical studies examining the effects of GLP-1 receptor agonists on resting metabolic rate (RMR) and total energy expenditure have produced consistent findings: these medications do not significantly increase metabolic rate

Accelerates recovery and comfort in joints, muscles, tendons, and ligaments

Many vitamin deficiencies are a result of poor diet

Approval was granted for adult obesity in 2021 for individuals with a BMI of 30 kg/m or 27 kg/m with comorbidities